New cancer clinical trial: 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

Published on: April 06, 2018 at 12:00PM
Condition:   Prostate Cancer Metastatic
Intervention:   Drug: 68Ga-PSMA-R2
Sponsor:   Advanced Accelerator Applications
Not yet recruiting
https://ift.tt/2qdGgw0